Evidence map›Paper›PMID 41640284›Full record

ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2026

Enhanced CD56 Expression and Increased Number of CD56

Emma Björk, Pernilla Israelsson, Olga Nagaeva, Lucia Mincheva-Nilsson, Ulrika Ottander

Abstract read
In one paragraph

Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Enhanced CD56 Expression and Increased Number of CD56American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emma BjörkDivision of Obstetrics and Gynecology/Örnsköldsvik Hospital, Örnsköldsvik, Sweden.ORCID 0009-0005-6920-5340
Pernilla IsraelssonDepartment of Diagnostics and Intervention/Oncology, Umeå University, Umea, Sweden.
Olga NagaevaDepartment of Clinical Microbiology/Infection and Immunology, Umeå University, Umea, Sweden.
Lucia Mincheva-NilssonDepartment of Clinical Microbiology/Infection and Immunology, Umeå University, Umea, Sweden.ORCID 0000-0001-6301-7940
Ulrika OttanderDepartment of Clinical Sciences/Obstetrics and Gynecology, Umeå University, Umea, Sweden.ORCID 0000-0002-1383-7753

Funding

Cancer Research Foundation in Northern Sweden (UO, and PI)Central ALF Funding (L.M-N), FUI Region Västernorrland (EB)Swedish National Cancer Research Foundation/Cancerfonden 18 07 17 L.M-NSwedish National Cancer Research Foundation/Cancerfonden CAN 2018/350Swedish Research Council/Vetenskapsrådet 18-20 - 345240311 L.M-N
6 · The paper itself

Abstract

problemNK-cell dysfunction in endometriosis is suggested to contribute to the survival of ectopic endometrial tissue. However, the underlying causes of this impairment remain unclear. NK cells are divided into: CD56 METHOD OF STUDY: NK-cell subpopulations and NKG2D receptor expression in PBMC were analyzed by flow cytometry in two cohorts of untreated and treated endometriosis patients and healthy age-matched controls.

resultsElevated numbers of CD56

conclusionsThe significantly increased proportion of peripheral CD56

Indexed as

CD56 AntigenEndometriosisEndometriumKiller Cells, NaturalAdultExosomesFemaleHumansNK Cell Lectin-Like Receptor Subfamily KYoung AdultCD56 AntigenKLRK1 protein, humanNCAM1 protein, humanNK Cell Lectin-Like Receptor Subfamily KCD56+brightendometriosisimmunosuppressive exosomesNK cellsNKG2D

Identifiers

PMID41640284
PMCPMC12873557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.